Kearns A E, Goto K, Gianakakos G, Lippmann W, Demay M B
Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Endocrinology. 1999 Sep;140(9):4120-6. doi: 10.1210/endo.140.9.6963.
The regulation of osteocalcin gene transcription is complex, involving multiple positive and negative regulators. Previous studies have demonstrated that an intronic sequence, TTTCTTT (+118 to +124) is capable of mediating transcriptional repression of osteocalcin-CAT fusion genes in cells of the osteoblast lineage, by interacting with a specific nuclear protein. Further analyses of intronic sequences have identified a second silencer motif in this region. Two copies of a CCTCCT motif are present within the first intron of the rat osteocalcin gene (+106 to +111 and +135 to +140) and are capable of mediating transcriptional repression of osteocalcin-CAT fusion genes in rat osteosarcoma cells. Transient gene expression assays of wild-type and mutant osteocalcin-CAT fusion genes into ROS 17/2.8 cells demonstrate that mutagenesis of either of these CCTCCT motifs in isolation results in a 1.6-fold increase in CAT activity relative to the parent fusion gene. Moreover, a 5-fold increase in reporter gene activity is observed when both motifs are mutated together. These sequences are also capable of suppressing osteocalcin promoter activity when placed upstream to the osteocalcin promoter. Gel retardation and southwestern analyses demonstrate that the CCTCCT motifs interact with specific proteins present in nuclear extracts from ROS 17/2.8 and UMR 106 osteosarcoma cells but not COS-7 kidney cells. Mutations that abolish suppressor function of this motif markedly impair interactions with this specific nuclear protein. These data demonstrate that at least two different silencer motifs (TTTCTTT and CCTCCT) in the first intron of the rat osteocalcin gene contribute to its transcriptional repression.
骨钙素基因转录的调控很复杂,涉及多个正调控因子和负调控因子。以往研究表明,一个内含子序列TTTCTTT(+118至+124)能够通过与一种特定的核蛋白相互作用,介导成骨细胞谱系细胞中骨钙素-CAT融合基因的转录抑制。对内含子序列的进一步分析在该区域鉴定出了第二个沉默子基序。大鼠骨钙素基因的第一个内含子(+106至+111以及+135至+140)中存在两个CCTCCT基序拷贝,它们能够介导大鼠骨肉瘤细胞中骨钙素-CAT融合基因的转录抑制。将野生型和突变型骨钙素-CAT融合基因瞬时导入ROS 17/2.8细胞的基因表达分析表明,单独对这两个CCTCCT基序中的任何一个进行诱变,相对于亲本融合基因,CAT活性会增加1.6倍。此外,当两个基序一起突变时,报告基因活性会增加5倍。当这些序列置于骨钙素启动子上游时,它们也能够抑制骨钙素启动子活性。凝胶阻滞和蛋白质免疫印迹分析表明,CCTCCT基序与ROS 17/2.8和UMR 106骨肉瘤细胞核提取物中存在的特定蛋白质相互作用,但不与COS-7肾细胞中的相互作用。消除该基序抑制功能的突变会显著削弱与这种特定核蛋白的相互作用。这些数据表明,大鼠骨钙素基因第一个内含子中至少有两个不同的沉默子基序(TTTCTTT和CCTCCT)有助于其转录抑制。